Dr. Sharief Taraman, MD, DABPN, DABPM, FAAP, is CEO of Cognoa, a leading early childhood development & pediatric behavioral health company. Neurodevelopment refers to the brain’s growth and maturation ...

Researchers review the future of schizophrenia treatment, highlighting TAAR1 agonists, NMDA enhancers, and the gut-brain axis ...

Jane, Julie, and Jemma are 6-year-old classmates. The three girls show several similarities in behaviour and cognition. All three struggle with starting new tasks, task-switching, sustaining attention ...

Non-invasive brain stimulation (NIBS) technologies are rapidly gaining prominence as effective tools for both investigating and modulating brain activity. As these technologies advance and evolve, ...

Neurological injuries can change life in an instant. A stroke, traumatic brain injury or progressive neurological disorder does not merely weaken muscles; it disrupts coordination, balance, perception ...

Researchers have found that the severity of autism symptoms, rather than the diagnosis itself, is linked to patterns of brain connectivity associated with genes connected to autism and ADHD.

Announcement follows FDA’s February 2025 decision to grant radiprodil Breakthrough Therapy designation Company remains on track to initiate Phase 3 pivotal trial of radiprodil in mid-2025 “We are ...

NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for ...

Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), is pleased to announce that it is receiving advisory services and funding from the National Research Council of Canada Industrial Research ...